| Literature DB >> 29149084 |
Bao Chen1,2, Yinghua Peng3, Xinhui Wang4, Zhiman Li5, Yinshi Sun6.
Abstract
Secoiridoid and iridoid glycosides are the main active components of Gentianaeradix. In this work, one iridoid and three secoiridoid glycosides from Gentianaeradix have been purified by high-speed counter-current chromatography in two runs using different solvent systems. Ethyl acetate-n-butanol-water (2:1:3, v/v/v) was the optimum solvent system to purify ca. 4.36 mg of loganic acid, 3.05 mg of swertiamarin, and 35.66 mg of gentiopicroside with 98.1%, 97.2% and 98.6% purities, respectively, while 31.15 mg of trifloroside with 98.9% purity was separated using hexane-ethyl acetate-methanol-water (1:3:1:3, v/v/v/v). The structures of the glycosides were identified by mass spectrometry and NMR. After separation, the anti-nitric oxide production effects of the compounds on lipopolysaccharide-induced BV-2 murine microglial cells were also evaluated. All of the compounds inhibited the production of nitric oxide in lipopolysaccharide-induced BV-2 cells with high cell viabilities in a concentration-dependent manner, which demonstrated that were able to be used as a nitric oxide inhibitor.Entities:
Keywords: Gentianae radix; anti-NO production effects; glycosides; high-speed counter-current chromatography (HSCCC); nitric oxide production
Mesh:
Substances:
Year: 2017 PMID: 29149084 PMCID: PMC6150402 DOI: 10.3390/molecules22112002
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
K values of the four compounds in different two-phase solvent systems.
| Solvent Systems ( | ||||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| ethyl acetate– | 0.22 | 0.35 | 0.54 | 11.92 |
| ethyl acetate– | 0.41 | 0.56 | 0.73 | 9.82 |
| hexane–ethyl acetate–methanol–water (1:1:1:1) | 0.49 | 9.00 | 0.00 | 0.01 |
| hexane–ethyl acetate–methanol–water (1:3:1:3) | 0.50 | 3.54 | 0.01 | 1.89 |
| hexane–ethyl acetate–methanol–water (1:4:1:4) | 0.55 | 2.95 | 0.17 | 3.78 |
Compound 1, loganic acid; Compound 2, swertiamarin; Compound 3, gentiopicroside; and Compound 4, trifloroside.
Figure 1HSCCC separation chromatograms of samples obtained from Gentianae radix. (A) Sample 1, ethyl acetate–n-butanol–water (2:1:3, v/v/v); and (B) Sample 2, hexane–ethyl acetate–methanol–water (1:3:1:3, v/v/v/v); sample size = 100 mg; flow rate = 5 mL/min; detection wavelength = 254 nm; revolution speed = 800 rpm.
Figure 2HPLC chromatograms of sample 1 and compounds 1–3 separated by HSCCC. (A) HPLC chromatogram of Sample 1; (B) HPLC chromatogram of compound 1; (C) HPLC chromatogram of compound 2; and (D) HPLC chromatogram of compound 3.
Figure 3HPLC chromatograms of (A) sample 2 and (B) compound 4 separated by HSCCC.
13C-NMR data of compounds 1–4 in DMSO-d6.
| Position | Compounds | |||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| 1 | 96.0 | 96.4 | 96.4 | 95.8 |
| 3 | 150.0 | 152.0 | 148.8 | 149.1 |
| 4 | 112.6 | 108.1 | 103.3 | 105.6 |
| 5 | 30.9 | 64.1 | 125.0 | 27.4 |
| 6 | 41.8 | 32.1 | 116.1 | 24.3 |
| 7 | 73.1 | 69.95 | 69.2 | 68.3 |
| 8 | 40.5 | 132.9 | 134.0 | 132.0 |
| 9 | 44.7 | 49.9 | 44.4 | 41.2 |
| 10 | 13.6 | 120.4 | 117.9 | 120.9 |
| 11 | 168.1 | 164.4 | 162.8 | 164.5 |
| 1′ | 98.5 | 98.3 | 98.8 | 96.8 |
| 2′ | 72.1 | 72.9 | 72.8 | 71.3 |
| 3′ | 76.8 | 77.4 | 77.4 | 70.8 |
| 4′ | 70.1 | 70.0 | 70.0 | 70.1 |
| 5′ | 77.2 | 76.1 | 76.6 | 71.7 |
| 6′ | 61.1 | 60.9 | 61.2 | 61.9 |
| 1′′ | 115.6 | |||
| 2′′ | 151.2 | |||
| 3′′ | 146.3 | |||
| 4′′ | 123.3 | |||
| 5′′ | 119.0 | |||
| 6′′ | 121.1 | |||
| 7′′ | 166.1 | |||
| 1′′′ | 102.0 | |||
| 2′′′ | 73.5 | |||
| 3′′′ | 76.3 | |||
| 4′′′ | 69.0 | |||
| 5′′′ | 77.5 | |||
| 6′′′ | 61.0 | |||
| O | 170.3 | |||
| 169.8 | ||||
| 169.1 | ||||
| OCO | 20.8 | |||
| 20.6 | ||||
| 20.5 | ||||
Figure 4Inhibition of LPS-induced NO in microglial BV-2 cells and the NO inhibition rate of (A) loganic acid; (B) swertiamarin; (C) gentiopicroside; and (D) trifloside. BV-2 cells were treated with the indicated concentrations of (±)-glycosides and LPS (200 ng/mL) for 24 h. The NO content in the media was measured and the amount of NO in the LPS (200 ng/mL) group was set as 100%. The data is presented as the mean ± SD from three independent experiments and the differences between the mean values were assessed by the Student’s t-test: # p < 0.05 compared to the control group; * p < 0.05, ** p < 0.01, and *** p < 0.001 compared to the LPS group.
Figure 5Effect of (A) longanic acid; (B) swertiamarin; (C) gentiopicroside; and (D) trifloroside on the cell viability of microglial BV-2 cells in LPS-treated or non-LPS-treated. BV-2 cells were treated with various concentrations of (±)-glycosides for 24 h and cell viabilities were monitored by crystal violet staining. Data are presented as means ± SD (n = 3 in each group).